Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Drops By 72.8%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a significant drop in short interest in June. As of June 15th, there was short interest totalling 4,100 shares, a drop of 72.8% from the May 31st total of 15,100 shares. Based on an average trading volume of 405,800 shares, the short-interest ratio is presently 0.0 days.

CNBX Pharmaceuticals Stock Performance

Shares of CNBX traded down $0.00 during mid-day trading on Thursday, hitting $0.01. 73,100 shares of the company traded hands, compared to its average volume of 267,336. The business has a 50 day moving average of $0.01 and a 200 day moving average of $0.01. CNBX Pharmaceuticals has a 1-year low of $0.01 and a 1-year high of $0.05.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.